Deodorant compositions

Abstract

This invention provides an effective, dermatologically safe composition based on partially carbonated magnesium hydroxide for use in cosmetic formulations.

Claims

1. A cosmetic formulation comprising a partially carbonated magnesium hydroxide (PCMH) of formula (1):
[Mg(OH).sub.2].sub.10-x.[MgCO.sub.3].sub.x.[H.sub.2O].sub.x(1) wherein x is a real number between about 1 and 7.

2. The cosmetic formulation according to claim 1 being perspiration-reducing formulation or deodorant formulation.

3. The cosmetic perspiration-reducing or deodorant formulation according to claim 2, comprising PCMH in an amount of from 5 to 30 wt %.

4. The cosmetic perspiration-reducing or deodorant formulation according to claim 2, wherein said PCMH consists of 20 to 85 wt % magnesium hydroxide, 12 to 65 magnesium carbonate, and 2 to 15 wt % water.

5. The cosmetic perspiration-reducing or deodorant formulation according to claim 2, comprising up to 10 wt % aluminum or zirconium salts.

6. The cosmetic perspiration-reducing or deodorant formulation according to claim 2, lacking aluminum or zirconium salts.

7. The cosmetic perspiration-reducing or deodorant formulation according to claim 2, comprising said partially carbonated magnesium hydroxide with solvents and optionally with additional components selected from surfactants, bulking agents, and fragrance components, said formulation exhibiting antimicrobial activity.

8. A dermatologically safe agent for use in cosmetic formulations, essentially consisting of a partially carbonated magnesium hydroxide (PCMH) of formula (1):
[Mg(OH).sub.2].sub.10-x.[MgCO.sub.3].sub.x.[H.sub.2O].sub.x(1) wherein x is a real number between about 1 and 7.

9. The dermatologically safe agent according to claim 8 being cosmetically active agent or perspiration-reducing agent or deodorant agent.

10. A method for reducing the amount of aluminum-based salts in deodorants and perspiration-reducing formulations or for replacing said salts, comprising i) providing cosmetically acceptable magnesium hydroxide and partially reacting it with carbon dioxide, wherein converting between about 10 and 70% of said hydroxide to carbonate, to provide a partially carbonated magnesium hydroxide (PCMH) essentially consisting of magnesium carbonate and water homogeneously dispersed in magnesium hydroxide; ii) mixing said PCMH with cosmetically acceptable solvents and/or surfactants, and optionally with additional components selected from surfactants, emollients, buffers, bulking agents, thickening agents, moisturizers, fragrance components, and preservatives, thereby obtaining a deodorant or perspiration-reducing formulation free of aluminum and zirconium salts, wherein said PCMH constitutes between 5 and 25 wt % of the formulation; and optionally iii) admixing to said formulation of step ii) up to 10 wt % of aluminum or zirconium salts, based on the weight of said formulation.

11. A method of manufacturing a cosmetic deodorant or perspiration-reducing formulation comprising steps of: i) providing cosmetically acceptable magnesium hydroxide and partially reacting it with carbon dioxide, wherein converting between about 10 and 70% of said hydroxide to carbonate, to provide a partially carbonated magnesium hydroxide (PCMH) essentially consisting of magnesium carbonate and water homogeneously dispersed in magnesium hydroxide; ii) mixing said PCMH with cosmetically acceptable solvents and/or surfactants; and optionally iii) mixing with additional components selected from emollients, buffers, bulking agents, thickening agents, moisturizers, fragrance components, and preservatives; thereby obtaining a safe deodorant or perspiration-reducing formulation, free of aluminum and zirconium salts.

12. The method of claim 11, comprising steps of (i) preparing an aqueous 10-40% slurry of magnesium hydroxide in a reactor; (ii) heating the slurry to 30-80 C. and stirring; (iii) injecting to the bottom of the reactor carbon dioxide for the time needed to the desired carbonation; and (iv) removing the partially carbonated magnesium hydroxide from the slurry and drying it to a moisture level of less than 2%, when measured as loss of drying at 105 C. for 60 minutes.

Description

BRIEF DESCRIPTION OF THE DRAWINGS

(1) The above and other characteristics and advantages of the invention will be more readily apparent through the following examples, and with reference to the appended drawings, wherein

(2) FIG. 1. shows the bulk density measurements for partially carbonized magnesium hydroxide (PCMH) in accordance with the invention (diamonds) and for comparative mixtures of magnesium hydroxide and carbonate (squares);

(3) FIG. 2. shows the tapped density measurements for partially carbonized magnesium hydroxide (PCMH) in accordance with the invention (diamonds) and for comparative mixtures of magnesium hydroxide and carbonate (squares);

(4) FIG. 3. shows the compressibility values calculated from the bulk densities and tapped densities, as a relative density increase, for partially carbonized magnesium hydroxide (PCMH) in accordance with the invention (diamonds) and for comparative mixtures of magnesium hydroxide and carbonate (squares);

(5) FIG. 4. shows the results of the sniffing test; left for untreated and right for treated group (with the deodorant based on PCMH), the first column being a comparative baseline;

(6) FIG. 5. shows the questionnaire answers;

(7) FIG. 6. shows the results of the perspiration-reducing efficacy test on the back;

(8) FIG. 7. is the relation between the carbonation time and the carbonation extent (in %) in one experimental arrangement according to the invention; and

(9) FIG. 8. shows SEM images, 10000 magnification, the abscissa corresponding to 5 m, of a PCMH10 sample according to the invention and a comparative example; 8A shows PCMH, 10% carbonization, according to the invention; 8B shows an artificial mixture of magnesium hydroxide and basic magnesium hydroxide tetrahydrate simulating 10% carbonization.

DETAILED DESCRIPTION OF THE INVENTION

(10) It has now been found that partially carbonated magnesium hydroxide (PCMH) is a suitable agent for use in cosmetic deodorant compositions. In one embodiment of the invention, the PCMH was prepared from an aqueous slurry of magnesium hydroxide, which was injected with carbon dioxide under controlled conditions, so that a defined portion of the magnesium hydroxide (MH) reacted to provide magnesium carbonate (MC); the slurry was dried to a moisture level of 2% or less, when measured, for example, as loss on drying at 105 C. for 60 minutes, and the powder was milled. For 10% carbonation for example, the reaction ran according to the following equation:
10Mg(OH).sub.2+1CO.sub.2=[Mg(OH).sub.2].sub.9.[MgCO.sub.3].[H.sub.2O]

(11) The right side of the equation shows the product which is a homogeneous mixture of magnesium hydroxide (about 83.5 wt %), magnesium carbonate (about 13.5 wt %) and water (about 3 wt %)constituting a PCMH product. The PCMH products were characterized by several parameters relevant for their use in cosmetic compositions, including their bulk density, tap density, etc. It was found that similar compositions obtained without carbonization, for example by mixing magnesium hydroxide (MH) with magnesium carbonate (MC) or by employing basic magnesium carbonate [BMC=(MgCO.sub.3).sub.4.Mg(OH).sub.2.4H.sub.2O], differed in their physical properties. For example, a mixture of about 12 wt % BMC and about 88 wt % of MH has an overall composition similar as PCMH shown in the above equation, but it exhibited higher bulk density (pour density) and also higher tapping density, the carbonated magnesium hydroxide being more fluffy than a physical mixture of components, and it kept this feature even after intensive tapping (see FIG. 1 and FIG. 2). Carbonated magnesium hydroxide exhibited higher tapping compressibility (FIG. 3). In various experiments, between 0% and 80% hydroxide was converted to carbonate (the extent of carbonation 0-80%). In a preferred embodiment of the invention, partially carbonated magnesium hydroxide comprising the carbonation extent of between about 5% and about 75%, preferably between about 10% and about 70% is used for preparing cosmetic perspiration-reducing and/or deodorant compositions of the invention. Partially carbonated magnesium hydroxide products comprising the carbonation extent of, for example, about 10% or about 70% are abbreviated here as PCMH10 and PCMH70, respectively.

(12) A cosmetic formulation in accordance with the invention usually comprises between 5 and 25 wt % PCMH, and the rest cosmetically acceptable surfactants and solvents, the formulation being, for example a stick, spray, roll-on, etc. The formulation usually exhibits antimicrobial activity, particularly antibacterial activity; for example, the formulation reduces the concentration of Staphylococcus species in vitro. Perspiration-reducing and deodorant formulations in accordance with the invention were prepared and tested; the tests showed a good perspiration-reducing and deodorant activity (FIG. 4, FIG. 5, FIG. 6). In some embodiments, the perspiration-reducing cosmetic formulation of the invention comprising a PCMH composition reduces the sweat formation, as measured by the back perspiration-reducing efficacy test, by at least about 10%, such as by at least 20%. The results of the sniffing test, as well as the questionnaire answers of volunteer users, confirm excellent potential of the PCMH composition for use in reducing perspiration and/or malodors. No irritation or sensitization was noticed in any one of the volunteer subjects. A composition containing PCMH may advantageously serve in safe cosmetic perspiration-reducing or deodorant formulations.

(13) Many perspiration-reducing or deodorant formulations contain at least 15 wt % of aluminum or aluminum-zirconium salts, and often up to 25 wt %. However, the majority of breast cancers occur close to the armpit where deodorants are applied, and aluminum is suspected, among other harmful effects, of being able to cause DNA alterations. A composition containing PCMH in accordance with the invention may substitute for a part of aluminum or aluminum-zirconium salts usually used in perspiration-reducing or deodorant formulations, or it may entirely replace the salts. In one aspect of the invention, the perspiration-reducing or deodorant formulations contain 10 wt % or less of aluminum or zirconium salts, for example less than 9 wt % or less than 8 wt % or less than 7 wt % or less than 6 wt % or less than 5 wt % aluminum or zirconium salts. In one embodiment of the invention, the perspiration-reducing or deodorant formulation contains up to 10 wt % aluminum or zirconium salts, for example up to 7 wt % or up to 6 wt % or up to 5 wt %. In another aspect of the invention, the perspiration-reducing or deodorant formulation is free of aluminum or zirconium salts.

(14) The PCMH product for cosmetic compositions in accordance with the invention preferably comprises partially carbonated magnesium hydroxide, in which carbon dioxide converts from about 5% to about 75% of magnesium hydroxide to magnesium carbonate, preferably from about 10% to about 70%, and more preferably from about 10% to about 50% magnesium hydroxide to magnesium carbonate.

(15) In preferred embodiments, the PCMH product in accordance with the invention comprises between about 20 and 85 wt % magnesium hydroxide, between about 12 and 65 magnesium carbonate, and between 2 and 15 wt % water. The PCMH in accordance with the invention will typically comprise magnesium carbonate (MC) being formed from magnesium hydroxide and carbon dioxide and being dispersed in magnesium hydroxide, MC being in an amount of about 5, about 10, about 20, about 30, about 40, about 50, about 60, or about 70 wt %, based on the total PCMH weight. The PCMH in accordance with the invention will typically comprise water being formed from magnesium hydroxide and carbon dioxide in an amount of about of up to 5, up to 10, or up to 15 wt % based on the total PCMH weight. When employing the term about before a value X, intended is the range of XX/5.

(16) The invention will be further described and illustrated in the following examples.

EXAMPLES

Example 1

(17) Partially carbonated magnesium hydroxide (PCMH) according to the invention was prepared, in one embodiment, from MH aqueous slurry, 10-40%, in a mixing tank. The slurry was heated to 30-80 C., and carbon dioxide was injected to the bottom of mixing shaft at an overpressure of 0.3-0.9 bar. The flow rate was adjusted, so that bubbles of gas appear on the mixture surface (excess of carbon dioxide). After certain reaction time, according to required carbonation extent, the process is stopped. The slurry was filtered and dried either in spray dryer or by another type of drying technology where exhausted gas temp is not less than 130-160 C. The moisture level of the dried material was less than 2%, when measured as loss of drying at 105 C. for 60 minutes. The dry powder was milled, and its content of magnesium hydroxide and water was determined, employing thermogravimetric analysis. The reaction time for a desired carbonation extent was assessed from a calibration curve, reaction time versus achieved carbonization, found for the relevant reaction arrangement. A calibration curve for a specific arrangement is shown in FIG. 7.

Example 2

(18) Comparative samples comprising magnesium hydroxide and magnesium carbonate of various ratios were prepared. In one series of experiments, basic magnesium carbonate [(MgCO3).sub.4.Mg(OH).sub.2.4H2O] was mixed with magnesium hydroxide, whereby simulating compositions obtained in accordance with the invention and having the same hydroxide/carbonate/water ratios.

(19) The content of free water was determined by loss on drying at 105 C. for 60 minutes. The content of bound water was determined by loss of drying at 180 C. for 30 minutes. The bulk density and tapped density were measured by pouring 50 g of powder into a volumetric cylinder; the bulk volume in ml was read immediately after pouring (V.sub.0), followed by 1000 tapping using a pharma test instrument and repeated reading of the volume (V.sub.1000). The bulk density and the tapped density were calculated (50/V). Compressibility was calculated: 100*(1-V.sub.1000/V.sub.0).

(20) Both types of materials, partially carbonated magnesium hydroxide in accordance with the invention and the simulating physical mixtures, were further characterized (not shown) by measuring nitrogen adsorption/desorption on the powders, BET, total pore volumes, average pore diameters, particle size distributions, XRD patterns and TGA profiles. The two types of powders, even though having similar chemical compositions, exhibited different physical properties (see, for example, the compressibility differences in FIG. 3) and micro-structure features (see, for example, SEM images in FIG. 8).

Experiment 3

(21) Deodorant formulations in accordance with the invention were prepared by mixing PCMH10 prepared according to the invention with cosmetically acceptable components according to the following tables:

(22) TABLE-US-00001 Component wt % 20% PCMH roll-on Water 58.62 xanthan gum 0.08 steareth-2 2.00 steareth-21 1.00 PPG 15-stearylether 3.00 fumed silica 0.50 cyclopentasiloxane 10.00 C12-15 alkylbenzoate 3.00 PCMH10 20.00 phenoxyethanol + ethylhexylglycerin 0.80 Perfume 1.00 20% PCMH stick cyclopentasiloxane 38.45 phenyltrimethicone 2.00 C12-15 alkylbenzoate 14.00 Petrolatum 1.50 Stearylalcohol 19.00 Trihydroxystearin 2.00 talc 1.00 PCMH10 20.00 BHT 0.05 Perfume 2.00

(23) TABLE-US-00002 Component wt % 25% PCMH spray cyclopentasiloxane 42.10 phenyltrimethicone 5.00 C12-15 alkylbenzoate 15.00 Bisabolol 0.20 Farnesol 0.30 ethylhexylglycerin 0.30 stearalkonium hectorite + propylene 6.00 carbonate + caprylic/capric triglyceride PCMH10 25.00 BHT 0.10 Perfume 6.00 Liquid/gas 15/85 10% PCMH + 10% Al/Zr roll-on water 40.05 xanthan gum 0.08 steareth-2 2.00 steareth-21 1.00 PPG 15-stearyl ether 3.00 fumed silica 0.50 cyclopentasiloxane 10.00 C12-15 alkyl benzoate 3.00 PCMH10 10.00 aluminum zirconium tetrachlor- 28.57 hydrex GLY-35% aq. solution phenoxyethanol + ethylhexyl glycerin 0.80 perfume 1.00

Experiment 4

(24) Sniff test was performed in Institute for Applied Dermatological Research, pro-DERM Hamburg, Germany, in June 2015, by experts (sniffers) trained for evaluating the efficacy of cosmetic products against axillary malodor. Twenty five subjects used the roll-on deodorant according to the invention. According to the results of the study, a significant difference in sweat odor rating was documented between the test product and the untreated control 24 hours after product application in favor of the test product (FIG. 4). The subjects filled in a questionnaire and expressed their subjective experience, mostly positive (FIG. 5); the subjects notices no sticky feel or unpleasant residues on the skin, no stains on clothes, and found the test product easy to spread.

Experiment 5

(25) Sensitizing properties of the roll-on deodorant according to the invention, was examined in the The Institute for Skin Reseach, Tel Aviv, Israel, on 50 volunteers. The hypoallergic test showed no allergic reaction for the deodorant of the invention.

Experiment 6

(26) Perspiration-reducing efficacy of the roll-on deodorant according to the invention was measured in the The Institute for Skin Research, Tel Aviv, Israel, on 10 volunteers. Gravimetrical assessment of the sweat quantity on the back of the subjects showed a reduction of 23% (FIG. 6).

Experiment 7

(27) Odor-reducing efficacy of the roll-on deodorant according to the invention, comprising 20% PCMH (as described in Example 3) was compared with a roll-on aluminum based deodorant containing 20% active material based on aluminum with otherwise same components. Six subjects (4 males, 2 females) used both deodorants in two armpits in parallel. Sniffers assessed both armpits every three hours from the time 0 to the time 24 hours, and scored the odor from 1 to 5, wherein 1 is no odor, 2 is weak, 3 is medium, 4 is strong, and 5 very strong. The average score for Al-based roll-on was 1.2 and for PCMH roll-on was 1.4.

Experiment 8

(28) The antimicrobial activity of formulation 20% PCMH roll-on as described in Example 3 was assessed according to a time-kill procedure ASTM E2315-03 in the Institute for Food Microbiology and Consumer Goods Ltd., Nesher, Israel. Two medically relevant types of bacteria which are a part of human skin flora, Staphylococcus epidermidis and Staphylococcus aureus, were exposed for two hours to the formulation and the reduction of their concentration was measured. As for S. epidermidis, formulation 20% PCMH roll-on according to the invention reduced its concentration by 99%, as for S. aureus, it could not be detected.

(29) While the invention has been described using some specific examples, many modifications and variations are possible. It is therefore understood that the invention is not intended to be limited in any way, other than by the scope of the appended claims.